Bluebird Bio Has Entered Into An Agreement To Sell A Rare Pediatric Disease Priority Review Voucher (PRV), If Received, In Connection With The Potential Approval Of Lovotibeglogene Autotemcel (Lovo-cel) For Sickle Cell Disease
Bluebird Bio Has Entered Into An Agreement To Sell A Rare Pediatric Disease Priority Review Voucher (PRV), If Received, In Connection With The Potential Approval Of Lovotibeglogene Autotemcel (Lovo-cel) For Sickle Cell Disease
Bluebird Bio已达成协议，如果收到，将出售罕见儿科疾病优先审查券（PRV），该凭证可能获准用于镰状细胞病的Lovotibeglogene Autotemcel（Lovo-cel）
Under the terms of the agreement, rights to the PRV will transfer to the buyer and the Company will receive $103 million upon closing of the sale, which is contingent upon the FDA's approval of the biologics license application (BLA) for lovo-cel and granting of the PRV.
根据协议条款，PRV的权利将转让给买方，该公司将在销售完成后获得1.03亿美元，这取决于美国食品药品管理局批准lovo-cel的生物制剂许可申请（BLA）并授予PRV。